Phaarmasia Ltd specializes in manufacturing pharmaceutical formulations like amexine, angicare, flamfort, and their therapeutic nasal spray, nasorel PR, falls under the antihistamine and sympathomimetic category.

Phaarmasia major competitors are Godavari Drugs, Murae Organisor, Biofil Chem & Pharma, Vista Pharma, Onyx Biotec, Bacil Pharma, Lasa Supergenerics.
Market Cap of Phaarmasia is ₹55 Crs.
While the median market cap of its peers are ₹55 Crs.

Phaarmasia seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.